SUMOylation can regulate the activity of ETS-like transcription factor 4

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1799, Issue 8, 2010, Pages 555-560

  Kaikkonen, Sanna ^a   Makkonen, Harri ^a   Rytinki, Miia ^a   Palvimo, Jorma J ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Covalent modification; ELK4 (SAP1); NET inhibitory domain (NID); SUMO 1; Transcription

Indexed keywords

PROTEIN C FOS; PROTEINASE; SENP1 PROTEIN; SENP2 PROTEIN; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR ELK 4; UNCLASSIFIED DRUG; CHAPERONE; CYSTEINE PROTEINASE; ELK4 PROTEIN, HUMAN; PIAS3 PROTEIN, HUMAN; PROTEIN INHIBITOR OF ACTIVATED STAT; SENP1 PROTEIN, HUMAN; SENP2 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL STRAIN COS1; CONJUGATION; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SUMOYLATION; AMINO ACID SEQUENCE; ANIMAL; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HELA CELL LINE; IMMUNOBLOTTING; METABOLISM; MOLECULAR GENETICS; PROTEIN PROCESSING; SEQUENCE HOMOLOGY; TRANSCRIPTION INITIATION;

AMINO ACID SEQUENCE; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; ETS-DOMAIN PROTEIN ELK-4; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE HOMOLOGY, AMINO ACID; SUMO-1 PROTEIN; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 77955664616     PISSN: 18749399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2010.07.001     Document Type: Article

References (28)

1. Buchwalter G., Gross C., Wasylyk B. Ets ternary complex transcription factors. Gene 2004, 324:1-14.
2. Dalton S., Treisman R. Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element. Cell 1992, 68:597-612.
3. Shaw P.E., Saxton J. Ternary complex factors: prime nuclear targets for mitogen-activated protein kinases. Int. J. Biochem. Cell Biol. 2003, 35:1210-1226.
4. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 2002, 4:131-136.
5. Janknecht R., Hunter T. Convergence of MAP kinase pathways on the ternary complex actor Sap-1a. EMBO J. 1997, 16:1620-1627.
6. Price M.A., Cruzalegui F.H., Treisman R. The p38 and ERK MAP kinase pathways cooperate to activate ternary complex factors and c-fos transcription in response to UV light. EMBO J. 1996, 15:6552-6563.
7. Maira S.M., Wurtz J.M., Wasylyk B. Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif. EMBO J. 1996, 15:5849-5865.
8. Criqui-Filipe P., Ducret C., Maira S.M., Wasylyk B. Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. EMBO J. 1999, 18:3392-3403.
9. Stinson J., Inoue T., Yates P., Clancy A., Norton J.D., Sharrocks A.D. Regulation of TCF ETS-domain transcription factors by helix-loop-helix motifs. Nucleic Acids Res. 2003, 31:4717-4728.
10. Hay R.T. SUMO: a history of modification. Mol. Cell 2005, 18:1-12.
11. Geiss-Friedlander R., Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 2007, 8:947-956.
12. Tatham M.H., Jaffray E., Vaughan O.A., Desterro J.M., Botting C.H., Naismith J.H., Hay R.T. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 2001, 276:35368-35374.
13. Rytinki M., Kaikkonen S., Pehkonen P., Jääskeläinen T., Palvimo J.J. PIAS proteins: pleiotropic interactors associated with SUMO. Cell. Mol. Life Sci. 2009, 66:3029-3041.
14. Hay R.T. SUMO-specific proteases: a twist in the tail. Trends Cell Biol. 2007, 17:370-376.
15. Ikonen T., Palvimo J.J., Jänne O.A. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J. Biol. Chem. 1997, 272:29821-29828.
16. Christian M., Tullet J.M., Parker M.G. Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140. J. Biol. Chem. 2004, 279:15645-15651.
17. Kotaja N., Aittomaki S., Silvennoinen O., Palvimo J.J., Jänne O.A. ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. Mol. Endocrinol. 2000, 14:1986-2000.
18. Bailey D., O'Hare P. Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1. J. Biol. Chem. 2004, 279:692-703.
19. Chalkiadaki A., Talianidis I. SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin. Mol. Cell. Biol. 2005, 25:5095-5105.
20. Kaikkonen S., Jääskeläinen T., Karvonen U., Rytinki M., Makkonen H., Gioeli D., Paschal B.M., Palvimo J.J. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells. Mol. Endocrinol. 2009, 23:292-307.
21. Makkonen H., Jääskeläinen T., Pitkänen-Arsiola T., Rytinki M., Waltering K.K., Mättö M., Visakorpi T., Palvimo J.J. Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells. Oncogene 2008, 27:4865-4876.
22. Rytinki M.M., Palvimo J.J. SUMOylation attenuates the function of PGC-1α. J. Biol. Chem. 2009, 284:26184-26193.
23. Rytinki M., Palvimo J.J. SUMOylation modulates the transcription repression function of receptor interacting protein 140. J. Biol. Chem. 2008, 283:11586-11595.
24. Yang S.H., Sharrocks A.D. SUMO promotes HDAC-mediated transcriptional repression. Mol. Cell 2004, 13:611-617.
25. Wasylyk C., Criqui-Filipe P., Wasylyk B. Sumoylation of the net inhibitory domain (NID) is stimulated by PIAS1 and has a negative effect on the transcriptional activity of Net. Oncogene 2005, 24:820-828.
26. Salinas S., Briançon-Marjollet A., Bossis G., Lopez M.A., Piechaczyk M., Jariel-Encontre I., Debant A., Hipskind R.A. SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1. J. Cell Biol. 2004, 165:767-773.
27. Giovane A., Pintzas A., Maira S.M., Sobieszczuk P., Wasylyk B. Net, a new ets transcription factor that is activated by Ras. Genes Dev. 1994, 8:1502-1513.
28. Demir O., Kurnaz I.A. Wildtype Elk-1, but not a SUMOylation mutant, represses egr-1 expression in SH-SY5Y neuroblastomas. Neurosci. Lett. 2008, 437:20-24.